EFFICACY AND SAFETY OF TOCILIZUMAB AS FIRST LINE THERAPY IN PATIENTS WITH RECENT POLYMYALGIA RHEUMATICA (PMR): RESULTS OF THE FIRST LONGITUDINAL PROSPECTIVE STUDY (TENOR)

被引：2

作者：

Devauchelle, V. ^{[1
]}

Berthelot, J. -M. ^{[2
]}

Cornec, D. ^{[1
]}

Renaudineau, Y. ^{[3
]}

Marhadour, T. ^{[4
]}

Jousse-Joulin, S. ^{[5
]}

Querellou, S. ^{[6
]}

Guarrigues, F. ^{[7
]}

De Bandt, M. ^{[8
]}

Gouillou, M. ^{[9
]}

Saraux, A. ^{[5
]}

机构：

[1] Brest Univ Hosp, Rheumatol, INSERM, ESPRI29, Brest, France

[2] Hotel Dieu Univ Hosp, Rheumatol, Nantes, France

[3] ESPRI 29, Immunol, EA 2216, Brest, France

[4] Brest Univ Hosp, Rheumatol, Brest, France

[5] Brest Univ Hosp, Brest, France

[6] Morvan Univ Hosp, Dept Nucl Med, Brest, France

[7] CHU Cavale Blanche, Radiol, Brest, France

[8] Univ Ft de France, Rheumatol, Fort De France, Martinique, France

[9] INSERM, Clin Invest Ctr CIC 1412, Brest, France

来源：

关键词：

D O I：

10.1136/annrheumdis-2015-eular.2727

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

FRI0280

引用

页码：526 / 526

页数：1